Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zibotentan for renal disease secondary to scleroderma (ZEBRA trial)
2013-003200-39Phase 2Completed
- Sponsor
- University College London
- Start
- Apr 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial in chronic kidney disease (CKD), Systemic sclerosis-associated renal disease (SSc-RD) and scleroderma renal crisis (SRC) comparing Zibotentan with Placebo (2 arms). Primary endpoint: Primary endpoint (ZEBRA1). Started Apr 2014; status: completed.
02
Drugs
zibotentan
03
Conditions
chronic kidney disease (CKD)Systemic sclerosis-associated renal disease (SSc-RD)scleroderma renal crisis (SRC)
Beyond the preview
Go deeper on 2013-003200-39.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2013-003200-39.